ST. LOUIS, Feb. 12 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. announced today that it intends to release its financial results for the quarter ended December 31, 2006, on Wednesday, February 21, 2007 before the market opens. The Company will also host a conference call with the investment community the same day at 8:30 a.m. ET.
To participate in the conference call, please dial 888-868-9083 (Domestic) or 973-935-8512 (International) a few minutes before 8:30 a.m. ET on Wednesday, February 21, 2007. A replay of the conference call will be available from 10:30 a.m. ET on February 21, 2007 until 9:30 a.m. ET on February 28, 2007. The replay dial in number is 877-519-4471 (Domestic) or 973-341-3080 (International). The replay pin number is 8437292.
The call will also be available on the Internet live and for 90 days thereafter at the following URL:
http://www.videonewswire.com/event.asp?id=37952
About Stereotaxis
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.
Forward Looking Statement
This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.
Contacts: Stereotaxis, Inc. 314-678-6105 Jim Stolze, Chief Financial Officer jstolze@stereotaxis.com Noonan Russo Matt Haines (investors) 212-845-4235 Noonan Russo Ben Carmichael (media) 212-845-4242
Stereotaxis, Inc.CONTACT: Jim Stolze, Chief Financial Officer, Stereotaxis, Inc.,+1-314-678-6105, jstolze@stereotaxis.com; or Matt Haines (investors),+1-212-845-4235, or Ben Carmichael (media), +1-212-845-4242, both of NoonanRusso
